Scarica l'app Stockscreener
0.9099
3.71%
-0.0351
Precedente Chiudi:
$0.945
Aprire:
$0.95
Volume 24 ore:
39,062
Relative Volume:
0.87
Capitalizzazione di mercato:
$3.78M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+10.96%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.86
$0.97
Intervallo di 1 settimana:
$0.77
$1.0594
Portata 52W:
$0.77
$1.51
Polyrizon Ltd Stock (PLRZ) Company Profile
Confronta PLRZ con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| PLRZ | 0.90 | 3.78M | 0 | 0 | 0 | 0.00 |
| VRTX | 449.69 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 748.75 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 588.46 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 247.89 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 106.23 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Polyrizon Ltd Borsa (PLRZ) Ultime notizie
Aegis Capital Corp. Acted as Sole Bookrunner on a $4.2 Million (IPO) Initial Public Offering for Polyrizon Ltd. (NASDAQ: PLRZ) - Quantisnow
PLRZPolyrizon Ltd. Ordinary Shares Latest Stock News & Market Updates - StockTitan
Polyrizon Announces Closing of $4.2 Million Initial Public Offering - The Manila Times
Polyrizon Prices 958.9K Share IPO at $4.38/unit By Investing.com - Investing.com South Africa
Polyrizon Prices 958.9K Share IPO at $4.38/unit - Investing.com
Polyrizon Announces Pricing of $4.2 Million Initial Public Offering and Listing on the Nasdaq Capital Market Under New Ticker 'PLRZ” - The Manila Times
Polyrizon Announces Pricing of $4.2 Million Initial Public Offering and Listing on the Nasdaq Capital Market Under New Ticker “PLRZ” - StockTitan
SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million - GlobeNewswire
Israel-Based Biotech Penny Stock SciSparc Outlicenses Its Cannabinoid Pain Therapy - Benzinga
SciSparc signs exclusive patent license agreement with Polyrizon - TipRanks
SciSparc Finalizes Exclusive Global Out-Licensing Agreement for its Pain Therapy Valued at $3 million - GlobeNewswire
Israeli biotech Polyrizon discloses terms for proposed $19M US IPO (NASDAQ:MDGS) - Seeking Alpha
Polyrizon Ltd Azioni (PLRZ) Dati Finanziari
Non sono disponibili dati finanziari per Polyrizon Ltd (PLRZ). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.80%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):